Literature DB >> 21270786

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

M V Relling1, T E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21270786      PMCID： PMC3098762          DOI： 10.1038/clpt.2010.279

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

Review 2.  Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective.

Authors:  Lawrence J Lesko; Janet Woodcock
Journal:  Nat Rev Drug Discov       Date:  2004-09       Impact factor: 84.694

3.  PharmGKB: a logical home for knowledge relating genotype to drug response phenotype.

Authors:  Russ B Altman
Journal:  Nat Genet       Date:  2007-04       Impact factor: 38.330

4.  Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges.

Authors:  P A Deverka; T Doksum; R J Carlson
Journal:  Clin Pharmacol Ther       Date:  2007-08-08       Impact factor: 6.875

5.  Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence.

Authors:  Diana B Petitti; Steven M Teutsch; Mary B Barton; George F Sawaya; Judith K Ockene; Thomas DeWitt
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

6.  Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism.

Authors:  Mary V Relling; Russ B Altman; Matthew P Goetz; William E Evans
Journal:  Lancet Oncol       Date:  2010-04-21       Impact factor: 41.316

Review 7.  Addressing the challenges of the clinical application of pharmacogenetic testing.

Authors:  O N Ikediobi; J Shin; R L Nussbaum; K A Phillips; J M Walsh; U Ladabaum; D Marshall
Journal:  Clin Pharmacol Ther       Date:  2009-07       Impact factor: 6.875

8.  Pharmacogenetic testing: not as simple as it seems.

Authors:  Susanne B Haga; Wylie Burke
Journal:  Genet Med       Date:  2008-06       Impact factor: 8.822

9.  Estimation of the warfarin dose with clinical and pharmacogenetic data.

Authors:  T E Klein; R B Altman; N Eriksson; B F Gage; S E Kimmel; M-T M Lee; N A Limdi; D Page; D M Roden; M J Wagner; M D Caldwell; J A Johnson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245
  9 in total
  374 in total

1.  Evolving research and stakeholder perspectives on pharmacogenomics.

Authors:  Amber L Beitelshees; David L Veenstra
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

2.  Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.

Authors:  A L Beitelshees; R B Horenstein; M R Vesely; M R Mehra; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

3.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

4.  GT2RDF: Semantic Representation of Genetic Testing Data.

Authors:  Anamika Paul Rupa; Sweta Singh; Qian Zhu
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

Review 5.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

6.  On not reinventing the wheel.

Authors: 
Journal:  Nat Genet       Date:  2012-02-27       Impact factor: 38.330

Review 7.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

Review 8.  Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Authors:  Katarzyna Drozda; Daniel J Müller; Jeffrey R Bishop
Journal:  Pharmacotherapy       Date:  2014-02       Impact factor: 4.705

Review 9.  The intelligent use and clinical benefits of electronic medical records in multiple sclerosis.

Authors:  Mary F Davis; Jonathan L Haines
Journal:  Expert Rev Clin Immunol       Date:  2014-12-11       Impact factor: 4.473

10.  Parental Perception of Self-Empowerment in Pediatric Pharmacogenetic Testing: The Reactions of Parents to the Communication of Actual and Hypothetical CYP2D6 Test Results.

Authors:  Sarah Adelsperger; Cynthia A Prows; Melanie F Myers; Cassandra L Perry; Ariel Chandler; Ingrid A Holm; John A Lynch
Journal:  Health Commun       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.